Your Equine Needs Under ONE Roof!

Your Equine Needs Under ONE Roof!

Tuesday, September 25, 2007

Respeze Clenbuterol

CLENBUTEROL is a adrenergic agonist. Its higly selective, direct mode of action relieves bronchospasm by causing the bronchial muscles to relax from their constricted state.


Throughout history, equine respiratory disease has limited the performance of horses and frustrated their owners. Because horses are active, athletic animlals, they need to be as physically fit and healthy as possible in order to perform to their full potential. This requires that their respiratory system be as effective as possible.

Even when the signs of disease are not obvious, respiratory disease can adversely affect your horse. It is essential to treat respiratory disease early. If respiratory disease is neglected, chronic changes in the airways may permanently and adversely affect your horses ability to breathe normally.

CLENBUTEROL main action is to relax airway smooth muscle, but it also improves the clearance of mucus by the ciliary escalator. Relaxation of smooth muscle and improved clearance of mucus and other secretions relieves airways obstruction and makes breathing easier.

CLENBUTEROL relieves reversible bronchospasm caused by respiratory condition such as:

. Allergy-induced respiratory distress
. Small airway disease (SAD)
. Heaves or chronic obstructive pulmonary disease (COPD)

ACTIVE CONSTITUENTS:
EACH ML CONTAINS

Clenbuterol hydrochloride BP 40ug

DOSSAGE

For best results give paste at least 30 minutes prior to feeding. Clenbuterol is well absorbed after oral administration, providing up to 12 hours duration of action.
Use twice daily to maintain a continuous beneficial effect. In chronic condition, lower dose treatment is recommended to provide a long term clinical effect.

ACUTE CONDITIONS
2ml/100kg body weight morning and night for 7 - 10 days

CHRONIC CONDITIONS
1 - 1.5ml/100kg body weight morning and night as required to provide long term control of symptoms

THE ONLY PROVEN FDA-APPROVED PRODUCT FOR REVERSIBLE RESPIRATORY DISEASE IN HORSES

No comments: